Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Collateral Agent Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Collateral Agent Agreement

Entities:

Interferon Sciences, Inc.

Date:

2006

Size:

Preview shows 5KB of 26KB total

Price:

$38

ID:

#2646873

 

 

► Securities ► Agent ► Collateral Agent Agreements
► Miscellany ► Watch List
► Biotech & Drugs ► Biological Products

 

 

Start of Preview


                           COLLATERAL AGENT AGREEMENT

--------------------------

COLLATERAL AGENT AGREEMENT (this "Agreement") dated as of November 16,
2006, among Barbara R. Mittman (the "Collateral Agent"), and the parties
identified on Schedule A hereto (each, individually, a "Lender" and
collectively, the "Lenders"), who hold or will acquire promissory Notes issued
or to be issued by Stem Cell Innovations, Inc. ("Parent"), a Delaware
corporation, at or about the date of this Agreement as described in the Security
Agreement referred to in Section 1(a) below (collectively herein the "Notes").

WHEREAS, the Lenders have made, are making and will be making loans to
Parent to be secured by certain collateral; and

WHEREAS, it is desirable to provide for the orderly administration of
such collateral by requiring each Lender to appoint the Collateral Agent, and
the Collateral Agent has agreed to accept such appointment and to receive, hold
and deliver such collateral, all upon the terms and subject to the conditions
hereinafter set forth; and

WHEREAS, it is desirable to allocate the enforcement of certain rights
of the Lenders under the Notes for the orderly administration thereof.

NOW, THEREFORE, in consideration of the premises set forth herein and
for other good and valuable consideration, the parties hereto agree as follows:

1. Collateral.
----------

(a) Contemporaneously with the execution and delivery of
this Agreement by the Collateral Agent and the Lenders, (i) the Collateral Agent
has or will have entered into a Security Agreement among the Collateral Agent,
Parent and Stem Cell Innovations BV, a Netherlands corporation, Amphioxus Cell
Technologies, Inc., a Delaware corporation (each a "Guarantor" and together with
Parent, "Debtors") ("Security Agreement"), regarding the grant of a security
interest in assets owned by Debtors (such assets are referred to herein and in
the Security Agreement as the "Collateral") to the Collateral Agent, for the
benefit of the Lenders, (ii) Parent is issuing the Notes to the Lenders pursuant
to a "Subscription Agreement" dated at or about the date of this Agreement.
Collectively, the Security Agreement, the Notes and Subscription Agreement and
other agreements referred to therein are referred to herein as "Borrower
Documents".

(b) The Collateral Agent hereby acknowledges that any
Collateral held by the Collateral Agent is held for the benefit of the Lenders
in accordance with this Agreement and the Borrower Documents. No reference to
the Borrower Documents or any other instrument or document shall be deemed to
incorporate any term or provision thereof into this Agreement unless expressly
so provided.

(c) The Collateral Agent is to distribute in accordance
with the Borrower Documents any proceeds received from the Collateral which are
distributable to the Lenders in proportion to their respective interests in the
Obligations as defined in the Security Agreement.

2. Appointment of the Collateral Agent.
-----------------------------------

The Lenders hereby appoint the Collateral Agent (and the
Collateral Agent hereby accepts such appointment) to take any action including,
without limitation, the registration of any Collateral in the name of the
Collateral Agent or its nominees prior to or during the continuance of an Event
of Default (as defined in the Borrower Documents), the exercise of voting rights

1
{PAGE}

upon the occurrence and during the continuance of an Event of Default, the
application of any cash collateral received by the Collateral Agent to the
payment of the Obligations, the making of any demand under the Borrower
Documents, the exercise of any remedies given to the Collateral Agent pursuant
to the Borrower Documents and the exercise of any authority pursuant to the
appointment of the Collateral Agent as an attorney-in-fact pursuant to the
Security Agreement that the Collateral Agent deems necessary or proper for the
administration of the Collateral pursuant to the Security Agreements. Upon
disposition of the Collateral in accordance with the Borrower Documents, the
Collateral Agent shall promptly distribute any cash or Collateral in accordance
with Section 10.4 of the Security Agreement. Lenders must notify Collateral
Agent in writing of the issuance of Notes to Lenders by Debtor. The Collateral

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC